Research - News
The intensive intervention was four hours a day, five days a week, for a total of 200 hours of face-to-face instruction, and neuroimaging revealed brain connectivity changes. 
From rapid diagnostic tools to next-generation therapies, UAB researchers are leading a multidisciplinary effort against traumatic brain injuries.
Neuron-derived microRNAs obtained from blood samples may correlate with treatment response and could aid the search for new therapeutics.
The computer brains inside autonomous vehicles will be fast enough to make life-or-death decisions. But should they? A member of UAB’s national championship-winning Bioethics Bowl team — and the team’s coach, a renowned bioethicist — weigh in on a thorny problem of the dawning robot age. 
Study shows that poor diet heightens hypersensitivity, which may amplify symptoms in chronic pain conditions.
Research suggests a link between short sleep and obesity from secondary eating and drinking while engaged in another activity.
Telemedicine helps UAB take pulmonary rehabilitation into the home via smartphone technology, in an effort to reduce hospital readmissions from COPD. 
Stylish but dangerous? UAB study looks at injuries caused by wearing high-heeled shoes. 
UAB researchers say how long your eyes take to adjust to the dark may be a risk factor for age-related macular degeneration.
UAB’s J. Crawford Downs, Ph.D., has received another grant to bring the relationship between age, intraocular pressure and glaucoma development into focus.
UAB is using an online survey to learn more about the relationship between diet and gout.
The methods used to gather data for the U.S. Dietary Guidelines are flawed and should be discarded, researchers say.
Research underway in UAB’s Mood Disorders Program is investigating promising new therapies, including novel drugs and low field magnetic stimulation.
The best breathing tube for out-of-hospital cardiac arrest is the subject of UAB-led national study.
Scientific breakthroughs can change the world—but only if they can break out of the lab first. Students in UAB’s biotechnology master’s program capitalize on UAB discoveries by translating them into new medical treatments and potential start-up companies. See how a mix of scientific knowledge and business sense helps them do it.
UAB Research Administration carefully invests to keep investigators competitive in an era of tight grant funding.
A UAB/Children’s of Alabama/Cincinnati Children’s study finds genetic risk for fatal inflammatory disorder linked to viral infection.
The Alzheimer’s plaques that accumulate around brain cells also congregate along the walls of blood vessels, according to UAB research, and that may contribute to cognitive issues.
A diabetes drug combined with exercise may help older adults regrow muscle, and UAB’s Center for Exercise Medicine is investigating.
HudsonAlpha opens a genomics clinic in Huntsville, part of a collaboration with UAB and Children’s of Alabama.
Renowned safety scientist Dean Sicking, Ph.D., is using high-tech dummies to tackle football's head-injury epidemic. In a unique facility, the Engineering professor and his team are precisely re-creating the game's collisions in order to improve helmet design.
A resin developed at the Materials Processing and Applications Development center is replacing the metal ring typically used to prevent cracks from furthering down an elephant’s tusk.
PhishMe is one of America’s fastest-growing private companies; Malcovery staff will remain at Birmingham’s Innovation Depot.
UAB leads a team that crafts new American College of Rheumatology guidelines for 2015 on treatment of rheumatoid arthritis.
The first large-scale trial of continuous chest compression following cardiac arrest shows little difference between the old and new methods of doing CPR.
Validated biomarkers are crucial to developing effective treatments for this degenerative disease.
Engineers, physicians, computer scientists and statisticians will collaborate to research and apply big data in the health care, industrial and smart cities fields.
A multisite study led by UAB has found the first biomarker for the onset of seizures in infants with tuberous sclerosis.
A UAB professor and student are examining how a new drug may improve life expectancies for CF patients and unplanned pregnancies among women.
UAB researchers will enroll patients for prospective studies on pathogenesis of a potentially fatal blood clot disorder with a $2.5 million NIH grant.